AM580 is a RARα-specific agonist that is already proven to protect from diet-induced hyperlipidemia and hepatic lipid accumulation by inhibiting Apolipoprotein C-III (ApoC-III) [29,30]. Here, APOC3 is linked to hyperlipidemia.